HTG Molecular Diagnostics: Christopher Kiritsy

HTG Molecular Diagnostics has appointed Christopher Kiritsy to its board. He is currently managing member of private investment and advisory firm Precision Kapital and cofounded and was president and CEO of Arisaph Pharmaceuticals. Before that, Kiritsy was executive VP of corporate development and CFO of Kos Pharmaceuticals.